US Patent Issued to UNIVERSITAT ZURICH on Jan. 20 for "Immunodominant proteins and fragments in multiple sclerosis" (Swiss Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,846, issued on Jan. 20, was assigned to UNIVERSITAT ZURICH (Zurich).

"Immunodominant proteins and fragments in multiple sclerosis" was invented by Mireia Sospedra Ramos (Zurich, Switzerland) and Roland Martin (Zurich, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to the treatment, diagnosis and/or prevention of multiple sclerosis (MS) by using an immunodominant protein or peptide. More particular the invention relates to the field of antigen specific immunotherapies, such as the induction of tolerance."

The patent was filed on June 28, 2019, under Application No. 17/253,282.

*For further information, including i...